Congenital afibrinogenemia Pipeline Analysis report covers drugs of 2 companies currently in different phases of development. Congenital afibrinogenemia is an autosomal recessive blood coagulation disorder which is caused by mutations in one of the three genes; FGA, FGB, or FGG. Each of these genes is responsible for making a subunit of a protein ( Read more...
Clostridium Difficile infections Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments.Clostridium Difficile infections Pipeline Analysis report covers drugs of 37 companies currently in different phases of development. Clostridium Difficile infections are caused by a bacterium, Clostridium difficile which causes diarrhoea and serious intestinal conditions known as colitis. Older people using antibiotics have a higher Read more...
Choroideremia Pipeline Analysis report covers 5 drugs currently in different phases of development. Choroideremia is a rare inherited disorder characterized by progressive vision loss due to degeneration of the choriocapillaris, retinal pigment epithelium, and the photoreceptor of the eye. Symptoms of the disease are night-blindness, vision loss in Read more...
Cachexia Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments.Cachexia Pipeline Analysis report covers 21 drugs currently in different phases of development. Cachexia or muscle wasting is a condition characterised by extreme weight loss and muscle wasting including body fat. It generally affects the people with serious disease such as cancer, HIV, ESRD etc. the loss or wastage may occur due to reasons such as change i Read more...
Autoimmune Hepatitis Pipeline Analysis report covers drugs of 7 companies currently in different phases of development. Autoimmune hepatitis is a long-lasting disease in which the body’s immune system fights against the normal liver cells instead of fighting against bacteria, viruses or other foreign substances. This gives rise to the liver inflammation leading to liver damage and failure. If diagnosed early, autoimmune hepatitis can be treated via immunosuppressive drugs. The exact cause of t Read more...
Alport Syndrome Pipeline Analysis report covers more than 5 drugs currently in different phases of development. Alport Syndrome is an inherited disorder involving the glomerular basement membrane of the kidney. The disease is characterized by loss of kidney function, hearing loss, and ophthalmic disorders. Symptoms of the disease are hematuria, nep Read more...
Alagille Syndrome Pipeline Analysis report covers therapies which include companies and research organizations or institutes, in total 4 in number currently in different phases of development. Alagille syndrome (ALGS) is a genetic disorder which occurs due to the mutations caused in either of the JAG1 or NOTCH2 gene. The genes instruct in making pr Read more...
Adrenoleukodystrophy is a rare genetic disorder characterised by loss or damage of myelin sheath surrounding and insulating the nerve cells. The damage of the myelin sheath further leads to the progressive loss of the fuctioning of the adrenal glands. Symptoms of adrenoleukodystrophy are muscle spasms and pain, impaired vision, trouble balancing the body, deterioration of motor control, Adrenal insufficiency and lethargy and clumsiness. Diagnosis is done using blood tests, Skin biopsy and fibr Read more...
Hairy cell leukemia Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments.Hairy cell leukemia Pipeline Analysis report covers drugs of 8 companies currently in different phases of development. Hairy cell leukemia is a rare type of white blood cells cancer where the bone marrow makes too many lymphocytes (B cells). B cells is one of the types of white blood cells which fight against infection. The excess B cells appear Read more...
Meningioma Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments.Meningioma Pipeline Analysis report covers 13 drugs currently in different phases of development. Meningioma is the tumor that develops in the layer called meninges which protect the brain and spinal cord. These are the most common form of tumors, slow growing and are mostly benign. When small in size meningioma may not cause any symptoms, however, larger Read more...
.jpg)
